12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers MyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 46.0% to $2.89 during Thursday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers GeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday’s after-market session. The market value of…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers ThermoGenesis Holdings (NASDAQ:THMO) stock moved upwards by 39.0% to $0.86 during Wednesday’s regular session. The market value…
Cosmos Health Announces Open Market Stock Purchases By The CEO; Mr Greg Siokas, Intends To Purchase An Aggregate Of Up To $3M In Common Shares Of The Company In The Open Market Through December 31, 2024
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of
Cosmos Health Enters Into Agreement To Acquire Rights For WIPO-Filed Patent On Drug Targeting CNS Cancers; No Financial Terms Disclosed
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical
Cosmos Health Announces Patent Filing For Its Obesity And Weight Management Product
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical
Over $5M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Thursday following the CPI data, there were a few notable insider trades.
COSMOS HEALTH CEO Issues Letter To Shareholders; Inaugural 2026 Guidance Introduced; Expects To Achieve Over $180M In Gross Annual Revenue And EBITDA In Excess Of $20M
Company reaches major strategic inflection point, with operations and revenue ramp-up underway, to significantly accelerate in 2024 and beyondMaintains solid balance sheet with negligible debt and strong, diversified
Cosmos Health Actively Exploring Spinoff Of R&D Division Into A Publicly Listed Standalone Biotech Company
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer
Cosmos Health Announces Strategic Collaboration With C.A.PAPAELLINAS Group Will Represent And Distribute Cosmos Health’s Proprietary Brand Of Nutraceuticals, Sky Premium Life In Holland & Barrett But Also In Pharmacies Throughout Cyprus
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer